106 related articles for article (PubMed ID: 16712832)
1. Successful ovulation in plasminogen-deficient mice treated with the broad-spectrum matrix metalloproteinase inhibitor galardin.
Liu K; Wahlberg P; Leonardsson G; Hägglund AC; Ny A; Bodén I; Wibom C; Lund LR; Ny T
Dev Biol; 2006 Jul; 295(2):615-22. PubMed ID: 16712832
[TBL] [Abstract][Full Text] [Related]
2. Skin wound healing in MMP2-deficient and MMP2 / plasminogen double-deficient mice.
Frøssing S; Rønø B; Hald A; Rømer J; Lund LR
Exp Dermatol; 2010 Aug; 19(8):e234-40. PubMed ID: 20163454
[TBL] [Abstract][Full Text] [Related]
3. Functional corpora lutea are formed in matrix metalloproteinase inhibitor-treated plasminogen-deficient mice.
Wahlberg P; Bodén I; Paulsson J; Lund LR; Liu K; Ny T
Endocrinology; 2007 Mar; 148(3):1226-34. PubMed ID: 17122079
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
[TBL] [Abstract][Full Text] [Related]
5. Effect of intrafollicular indomethacin injection on gonadotropin surge-induced expression of select extracellular matrix degrading enzymes and their inhibitors in bovine preovulatory follicles.
Li Q; Jimenez-Krassel F; Kobayashi Y; Ireland JJ; Smith GW
Reproduction; 2006 Mar; 131(3):533-43. PubMed ID: 16514196
[TBL] [Abstract][Full Text] [Related]
6. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic overlap between MMP-13 and the plasminogen activation system during wound healing in mice.
Juncker-Jensen A; Lund LR
PLoS One; 2011 Feb; 6(2):e16954. PubMed ID: 21326869
[TBL] [Abstract][Full Text] [Related]
8. Studies of mice lacking plasminogen activator gene function suggest that plasmin production prior to ovulation exceeds the amount needed for optimal ovulation efficiency.
Ny A; Nordström L; Carmeliet P; Ny T
Eur J Biochem; 1997 Mar; 244(2):487-93. PubMed ID: 9119016
[TBL] [Abstract][Full Text] [Related]
9. Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogen.
Green KA; Almholt K; Ploug M; Rønø B; Castellino FJ; Johnsen M; Bugge TH; Rømer J; Lund LR
J Invest Dermatol; 2008 Aug; 128(8):2092-101. PubMed ID: 18337830
[TBL] [Abstract][Full Text] [Related]
10. Galardin inhibits collagen degradation by rabbit keratocytes by inhibiting the activation of pro-matrix metalloproteinases.
Hao JL; Nagano T; Nakamura M; Kumagai N; Mishima H; Nishida T
Exp Eye Res; 1999 May; 68(5):565-72. PubMed ID: 10328970
[TBL] [Abstract][Full Text] [Related]
11. A functional overlap of plasminogen and MMPs regulates vascularization during placental development.
Solberg H; Rinkenberger J; Danø K; Werb Z; Lund LR
Development; 2003 Sep; 130(18):4439-50. PubMed ID: 12900459
[TBL] [Abstract][Full Text] [Related]
12. Reduced transplant arteriosclerosis in plasminogen-deficient mice.
Moons L; Shi C; Ploplis V; Plow E; Haber E; Collen D; Carmeliet P
J Clin Invest; 1998 Nov; 102(10):1788-97. PubMed ID: 9819364
[TBL] [Abstract][Full Text] [Related]
13. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.
Liu Z; Li N; Diaz LA; Shipley M; Senior RM; Werb Z
J Clin Invest; 2005 Apr; 115(4):879-87. PubMed ID: 15841177
[TBL] [Abstract][Full Text] [Related]
14. Impact of extracellular matrix remodeling on ovulation and the folliculo-luteal transition.
Curry TE; Smith MF
Semin Reprod Med; 2006 Sep; 24(4):228-41. PubMed ID: 16944420
[TBL] [Abstract][Full Text] [Related]
15. Ovulation in plasminogen-deficient mice.
Ny A; Leonardsson G; Hägglund AC; Hägglöf P; Ploplis VA; Carmeliet P; Ny T
Endocrinology; 1999 Nov; 140(11):5030-5. PubMed ID: 10537128
[TBL] [Abstract][Full Text] [Related]
16. Expression of protease nexin-1 and plasminogen activators during follicular growth and the periovulatory period in cattle.
Cao M; Buratini J; Lussier JG; Carrière PD; Price CA
Reproduction; 2006 Jan; 131(1):125-37. PubMed ID: 16388016
[TBL] [Abstract][Full Text] [Related]
17. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function.
Smith MF; McIntush EW; Ricke WA; Kojima FN; Smith GW
J Reprod Fertil Suppl; 1999; 54():367-81. PubMed ID: 10692869
[TBL] [Abstract][Full Text] [Related]
18. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
19. Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems.
Ny T; Wahlberg P; Brändström IJ
Mol Cell Endocrinol; 2002 Feb; 187(1-2):29-38. PubMed ID: 11988309
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
